Author:
Humeniuk R,Rosu-Myles M,Fares J,Koller R,Bies J,Wolff L
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Cogle CR, Craig BM, Rollison DE, List AF . Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries. Blood 2011; 117: 7121–7125.
2. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB . Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997; 57: 837–841.
3. Drexler HG . Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998; 12: 845–859.
4. Markus J, Garin MT, Bies J, Galili N, Raza A, Thirman MJ et al. Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16). Cancer Res 2007; 67: 992–1000.
5. Tien HF, Tang JH, Tsay W, Liu MC, Lee FY, Wang CH et al. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation. Br J Haematol 2001; 112: 148–154.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献